Ribociclib added to endocrine therapy extends survival in postmenopausal patients with metastatic breast cancer

A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. This is the first demonstration of a survival advantage with a front-line CDK4/6…

PRO grilling tips for pro tailgaters

Football season is back in full swing. Stadiums are filling up with fans again, and grilling in stadium parking lots and at backyard cookouts are back with the gridiron season. The food fun includes fans at high schools, colleges and NFL games. And just like sports fans need to take certain precautions to stop the……